https://orcid.org/0000-0002-9668-0316
References
- Sharara AI , AlAwadhi S, AlharbiOet al. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East. Expert Rev. Gastroenterol. Hepatol.12(9), 883–897 (2018).
- Parks AG , NichollsRJ. Proctocolectomy without ileostomy for ulcerative colitis. Br. Med. J.2(6130), 85–88 (1978).
- oksanen P , HuhtalaH, HaapamäkiJ, aitolaP. Health-related quality of life after restorative proctocolectomy: a cross-sectional study. Scand. J. Surg.107(4), 315–321 (2018).
- Shen B , KochharGS, El-HachemSet al. Diagnosis and classification of ileal pouch disorders: consensus guidelines from the International Ileal Pouch Consortium. Lancet Gastroenterol. Hepatol.6(10), 826–849 (2021).
- Chowdhry S , KatzJA. Update on the pathogenesis and management of pouchitis. Curr. Infect. Dis. Rep.16(12), 1–5 (2014).
- Falk A , OlssonC, AhrnéS, MolinG, AdawiD, JeppssonB. Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. Scand. J. Gastroenterol.42(8), 973–985 (2007).
- Sartor RB . Microbial influences in inflammatory bowel diseases. Gastroenterology134(2), 577–594 (2008).
- Madden MV , McIntyreAS, NichollsRJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig. Dis. Sci.39(6), 1193–1196 (1994).
- Shen B , FazioVW, RemziFHet al. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. Dis. Colon Rectum50(4), 498–508 (2007).
- Gionchetti P , RizzelloF, HelwigUet al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology124(5), 1202–1209 (2003).
- Gionchetti P , RizzelloF, MorselliCet al. High-dose probiotics for the treatment of active pouchitis. Dis. Colon Rectum50(12), 2075–2084 (2007).
- Persborn M , GerritsenJ, WallonCet al. The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. Aliment. Pharmacol. Ther.38(11–12), 772–783 (2013).
- Nicholls RJ , BelliveauP, NeillM, WilksM, TabaqchaliS. Restorative proctocolectomy with ileal reservoir: a pathophysiological assessment. Gut22(6), 462–468 (1981).
- Santavirta J , MattilaJ, KokkiM, MatikainenM. Mucosal morphology and faecal bacteriology after ileoanal anastomosis. Int. J. Colorectal Dis.6(1), 38–41 (1991).
- H Ruseler-van Embden JG , SchoutenWR, Cvan Lieshout LM. Pouchitis: result of microbial imbalance?Gut35(35), 658–664 (1994).
- Kmiot WA , YoungsD, TudorR, ThompsonH, KeighleyMRB. Mucosal morphology, cell proliferation and faecal bacteriology in acute pouchitis. Br. J. Surg.80(11), 1445–1449 (2005).
- O’Connell PR , RankinDR, WeilandLH, KellyKA. Enteric bacteriology, absorption, morphology and emptying after ileal pouch-anal anastomosis. Br. J. Surg.73(11), 909–914 (1986).
- Iwaya A , IiaiT, OkamotoHet al. Change in the bacterial flora of pouchitis. Hepatogastroenterology53(67), 55–59 (2006).
- Kühbacher T , OttSJ, HelwigUet al. Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut55(6), 833–841 (2006).
- McLaughlin SD , WalkerAW, ChurcherCet al. The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann. Surg.252(1), 90–98 (2010).
- Zella GC , HaitEJ, GlavanTet al. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm. Bowel Dis.17(5), 1092–1100 (2011).
- Machiels K , SabinoJJ, VandermostenLet al. Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut66(1), 79–88 (2017).
- Maharshak N , CohenNA, ReshefL, TulchinskyH, GophnaU, DotanI. Alterations of enteric microbiota in patients with a normal ileal pouch are predictive of pouchitis. J. Crohn’s Colitis11(3), 314–320 (2017).
- Dubinsky V , ReshefL, BarNet al. Predominantly antibiotic-resistant intestinal microbiome persists in patients with pouchitis who respond to antibiotic therapy. Gastroenterology158(3), 610–624.e13 (2020).
- Kayal M , LambinT, PinottiR, DubinskyMC, GrinspanA. A systematic review of fecal microbiota transplant for the management of pouchitis. Crohn’s Colitis 3602(2), otaa034 (2020).